search

Active clinical trials for "Carcinoma, Hepatocellular"

Results 1451-1460 of 2402

Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge...

Hepatocellular CarcinomaHCC

This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing orthotopic liver transplantation. We propose that SBRT will be associated with longer time intervals between initial treatment and the need for retreatment, compared to TACE, as a "bridge" to orthotopic liver transplantation.

Completed15 enrollment criteria

Preoperative Pain Control in Liver Surgery Patients

PainPostoperative1 more

Pregabalin 150mg or placebo are administered 1 hour preoperatively in patients undergoing partial hepatectomy. Postoperatively, patients receive morphine as rescue analgesic. Morphine consumption in the first 48 hours is documented. Postoperative pain is measured by the visual analogue scale (VAS) score.

Completed10 enrollment criteria

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma...

Liver Carcinoma

This study investigates whether sirolimus could decrease the rate of hepatoma recurrence after liver transplantation in high risk hepatoma patients.

Completed2 enrollment criteria

Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor...

Hepatocellular Carcinoma

According to radiology imaging, the patients of HCC are divided into two groups(hypovascular tumor group and moderately vascular tumor group). Every group is divided into TACE therapy with balloon catheter subgroup and regular TACE therapy subgroup. Patients take the TACE therapy each 45 days, and have MRI diffusion examine or CT one week before next therapy. All objects are observed until the end event happening or in the group for 6 months.

Completed5 enrollment criteria

Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not...

Liver CancerHepatoma

Fewer than 15% of hepatoma patients are suitable candidates for surgical removal of their cancer. The purpose of this protocol is to provide supervised access at Oregon Health and Science University to Y-90 treatment to provide these patients access to an alternate therapy. The radioactive beads are placed directly near or into the liver tumor with the intention of destroying the tumor cells.

Completed14 enrollment criteria

Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in...

Unresectable Hepatocellular Carcinoma

Certain cancers require the amino acid arginine. Arginine deiminase (ADI) is an enzyme from microbes that degrade arginine. ADI has been formulated with polyethylene glycol and has been used to treat patients that have cancers that require arginine. In this study, the investigators will evaluate the response rate, as determined by the revised International Working Group recommendations.

Completed16 enrollment criteria

Extracellular RNA Markers of Liver Disease and Cancer

Hepatocellular CarcinomaBiliary Tract Cancer2 more

The study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction of response to treatment or recurrence of cancer after surgery

Active8 enrollment criteria

Standard Treatments of Very-early Stage Hepatocellular Carcinoma

Hepatocellular CarcinomaVery-early Stage

The aim of our study was to elucidate the difference in the rates of complication, hospitalization days, medical expenses, MRI showed that the degree of tumor necrosis, and overall survival rates of the therapies between PEI, MVA and RFA, and make the standard for minimally invasive treatment of very early stage HCC.

Completed12 enrollment criteria

A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1"...

Hepatocellular Carcinoma

A clinical trial to compare the pharmacokinetics and bioequivalence of BR2008 with BR2008-1 in healthy volunteers

Completed26 enrollment criteria

Resection for Multiple Hepatocellular Carcinomas (HCC)

Hepatocellular CarcinomaMultiple Tumors1 more

Surgical resection in patients with multiple hepatocellular carcinomas (HCC) remains controversial. The aim of this study was to investigate the outcome of a consecutive cohort of patients resected for multiple HCC, without macrovascular invasion, in order to identify clinically reliable parameters to select patients for surgery.

Completed4 enrollment criteria
1...145146147...241

Need Help? Contact our team!


We'll reach out to this number within 24 hrs